Golimumab

SIMPONI ARIA, Simponi

Tumor Necrosis Factor Blocker

NADAC/unit $12974.5178

No Shortage Tier 1: 3.6% PA Req: 19.5%

Golimumab suppresses inflammation by blocking tumor necrosis factor, used in autoimmune conditions.

vs. brand SIMPONI ARIA: Generic saves up to -129645% per unit

Covered Lives

Explore in the Ecosystem

rxsaver.aiCompare prices for Golimumab drfinder.aiFind doctors who prescribe Golimumab rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Golimumab

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.